-+ 0.00%
-+ 0.00%
-+ 0.00%

Amneal Pharmaceuticals Sees FY2026 Adj EPS $0.93-$1.03 vs $0.94 Est; Sees Sales $3.050B-$3.150B vs $3.210B Est

Benzinga·02/27/2026 11:01:44
Listen to the news
Amneal Pharmaceuticals (NASDAQ:AMRX) is looking for FY2026 Adj EPS of $0.93-$1.03 vs $0.94 analyst estimate. sees sales of $3.050 billion-$3.150 billion vs $3.210 billion analyst estimate.